Tao Zhou
- Cancer Research top 5%
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 17
- RNA Research and Splicing 11
- RNA modifications and cancer 6
- Immunology top 5%
- interferon and immune responses 9
- Cell Biology top 5%
- Microtubule and mitosis dynamics 11
- Endoplasmic Reticulum Stress and Disease 6
- Oncology top 10%
- Cancer-related Molecular Pathways 8
-
- Autophagy in Disease and Therapy 9
- Journals
- Nature Communications (6 papers)Biochemical and Biophysical Research Communications (5 papers)Autophagy (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Tao Zhou
93 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 557
- Molecular Biology 2.0k
- Immunology 525
- Cell Biology 269
- Oncology 414
Countries citing papers authored by Tao Zhou
This map shows the geographic impact of Tao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Zhou more than expected).
Fields of papers citing papers by Tao Zhou
This network shows the impact of papers produced by Tao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Zhou. The network helps show where Tao Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 30 | |
| 8 | 2023 | 25 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 40 | |
| 11 | 2019 | 37 | |
| 12 | Vascular endothelial growth factor (VEGF) rs3025039 polymorphism is associated with increased risk of osteosarcoma | 2017 | 2 |
| 13 | 2017 | 9 | |
| 14 | 2014 | 47 | |
| 15 | 2014 | 1 | |
| 16 | 2013 | 44 | |
| 17 | 2012 | 62 | |
| 18 | 2010 | 58 | |
| 19 | 2007 | 60 | |
| 20 | 2006 | 24 |
About Tao Zhou
Tao Zhou is a scholar working on Aging, Cell Biology and Molecular Biology, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Microtubule and mitosis dynamics (11 papers), RNA Research and Splicing (11 papers), interferon and immune responses (9 papers), Autophagy in Disease and Therapy (9 papers), Cancer-related Molecular Pathways (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (557 citations), Molecular Biology (2.0k citations) and Immunology (525 citations). Tao Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Huiyan Li, Ailing Li, Xuemin Zhang, Xin Pan, Tao Li, Xue-Min Zhang, Jiang-Hong Man, Kun He, Wei-Li Gong and Qiuying Han. Their work appears in journals such as Nature Communications, Biochemical and Biophysical Research Communications, Autophagy, Journal of Proteome Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.